News & Events

• April 1, 2015
  

  Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects

  Pai M, Schito M. Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects. The Journal of Infectious Diseases. 2015 Apr 1;211 Suppl 2:S21–8.

• April 1, 2015
  

  Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers

  Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD. Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers. The Journal of Infectious Diseases. 2015 Apr 1;211 Suppl 2:S39–49.

• March 1, 2015
  

  Alzheimer’s and Parkinson’s Diseases Face Common Challenges in Therapeutic Development: Role of the Precompetitive Consortium, Coalition Against Major Diseases

• March 1, 2015
  

  The Future Is Now: Model‐based Clinical Trial Design For Alzheimer’s Disease

• March 1, 2015
  

  Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease

  Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C. Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease. Expert Review of Neurotherapeutics. 2015 Mar;15(3):327–33.